Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012.
Euro Surveill
; 17(49)2012 Dec 06.
Article
em En
| MEDLINE
| ID: mdl-23231892
ABSTRACT
A rapid survey by the European Centre for Disease Prevention and Control (ECDC) and the World Health Organization (WHO) Regional Office for Europe ascertained the availability of national reference laboratory testing for a recently detected novel coronavirus as of 28 November 2012. Screening by internal quality controlled upE-RT-PCR assay was available in 23/46 of responding countries in the WHO European Region, of which 19/30 in European Union (EU) and European Economic Area (EEA) countries. Confirmation of positive screened samples by either ORF1b - RT-PCR, or other target RT-PCR assays with sequence analysis or whole-genome sequence analysis was available in 22/46 responding countries of which 18/30 in EU/EEA countries.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Infecções por Coronavirus
/
Coronavirus
/
Reação em Cadeia da Polimerase Via Transcriptase Reversa
/
Laboratórios
Tipo de estudo:
Diagnostic_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2012
Tipo de documento:
Article